Last reviewed · How we verify
Cannabis Sativa extract Oromucosal spray
Cannabis Sativa extract Oromucosal spray is a Small molecule drug developed by Ospedale San Raffaele. It is currently in Phase 2 development. Also known as: Sativex.
At a glance
| Generic name | Cannabis Sativa extract Oromucosal spray |
|---|---|
| Also known as | Sativex |
| Sponsor | Ospedale San Raffaele |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Anesthetic Premedication With a Cannabis Extract (Cannapremed) (PHASE2, PHASE3)
- A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis (PHASE3)
- A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy (PHASE3)
- Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain (PHASE3)
- Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan) (PHASE1)
- Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cannabis Sativa extract Oromucosal spray CI brief — competitive landscape report
- Cannabis Sativa extract Oromucosal spray updates RSS · CI watch RSS
- Ospedale San Raffaele portfolio CI
Frequently asked questions about Cannabis Sativa extract Oromucosal spray
What is Cannabis Sativa extract Oromucosal spray?
Cannabis Sativa extract Oromucosal spray is a Small molecule drug developed by Ospedale San Raffaele.
Who makes Cannabis Sativa extract Oromucosal spray?
Cannabis Sativa extract Oromucosal spray is developed by Ospedale San Raffaele (see full Ospedale San Raffaele pipeline at /company/ospedale-san-raffaele).
Is Cannabis Sativa extract Oromucosal spray also known as anything else?
Cannabis Sativa extract Oromucosal spray is also known as Sativex.
What development phase is Cannabis Sativa extract Oromucosal spray in?
Cannabis Sativa extract Oromucosal spray is in Phase 2.
Related
- Manufacturer: Ospedale San Raffaele — full pipeline
- Also known as: Sativex
- Compare: Cannabis Sativa extract Oromucosal spray vs similar drugs
- Pricing: Cannabis Sativa extract Oromucosal spray cost, discount & access